跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Lexibase - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Lexibase
Approved
STANDARD
Lexibase
Lloyd Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
5e38816baa42c232
Company
Lloyd Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
5e38816baa42c232
Drug Approval Philippines Name
Lexibase
Product Name
Lexibase
Registration Number
DR-XY17074-B
Brand Name
Lexibase
Generic Name
Cefalexin (As Monohydrate)
Dosage Form
Powder For Suspension (Oral Drops)
Dosage Strength
100 mg/mL
Manufacturer
Lloyd Laboratories, Inc.
Trader
Basic Pharmaceutical Corporation
Issuance Date
26 May 2022
Expiry Date
29 July 2027
Pharmacologic Category
Antibacterial (Cephalosporin)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
5e38816baa42c232
Type
Standard
Back to Philippines FDA Approvals